Table 2.

Characteristics and Histopathological Diagnosis of Cytologically Indeterminate/GEC Benign Nodules That Underwent Resection

n	Age, y	Sex	Nodule Size (Initial), cm	Cytology	Time to Resection, mo	Nodule Size (final), cm	Reasons for Resection	Histopathology
1	35	F	2.2	AUS	0	n/a	Patient decision	Follicular adenoma
2	56	F	1.7	AUS	0	n/a	Second nodule requiring surgery	Nodular hyperplasia
3	54	F	1.3	AUS	0	n/a	Second nodule requiring surgery	Adenomatous nodule
4	77	F	1.1	SFN	0	n/a	Second nodule requiring surgery	Adenomatous nodule
5	45	M	2.0	SFN	0	n/a	History of EBRT; patient decision	Adenomatous nodule
6	42	F	1.4	AUS	7	1.7	History of EBRT with FDG-PET avidity	Adenomatous nodule
7	58	F	2.7	AUS	12	2.9	History of EBRT with nodule hypervascularity	Follicular adenoma
8	52	F	3.0	SFN	14	3.5	Nodule growth	Minimally invasive FTC
9	21	F	2.2	AUS	7	2.8	Nodule growth; repeat FNA benign	Nodular hyperplasia
10	31	F	4.3	SFN	8	4.6	Nodule growth	Nodular hyperplasia
11	57	M	2.0	AUS	6	2.3	Nodule growth; repeat FNA benign	Nodular hyperplasia
12	59	F	2.7	AUS	9	2.9	Nodule growth; repeat FNA SFN	Follicular adenoma
13	42	F	2.3	SFN	19	2.6	Nodule growth	Follicular adenoma

Abbreviations: AUS, aytpia of undetermined significance; EBRT, external beam radiation treatment; FDG-PET, fluorodeoxyglucose positron emission tomography; F, female; M, male; n/a, not applicable; SFN, suspicious for follicular neoplasm.